Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver disease

Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver disease - Identification of novel serum biomarkers for NAFLD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033887

Enrollment

Registered

2018-08-24

Start date

2021-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

Healthy volunteer Abdominal ultrasound echo:Once Blood draw:Once Simple steatosis patient previously diagnosed by liver biopsy Blood draw:Once Non-alcoholic steatohepatitis patient previosly diag

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteer 1)Written informed consent is required. 2)Individuals of 40-69 years old. Patient of non-alcoholic fatty liver disease 1)Written informed consent is required.

Exclusion criteria

Exclusion criteria: Healthy volunteer 1)Individuals diagnosed as fatty liver by abdominal ultrasound echo.

Design outcomes

Primary

Measure	Time frame
We will quantitate the levels of novel serum biomarkers using the sera from healthy volunteers, simple steatosis patients, and non-alcoholic steatohepatitis patients. The results will be statistically analyzed to explore their usefulness.	—

Countries

Japan

Contacts

Public ContactYuichi Tsuchiya

Toho University School of Medicne Division of Biochemistry, Department of Biochemistry

tsuchiya@phar.toho-u.ac.jp047-472-9199

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026